🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
161.20
+1.77 (1.11%)
At close: Nov 20, 2026, 4:00 PM EST
165.79
+4.59 (2.85%)
After-hours: Nov 20, 2026, 7:58 PM EST

Revolution Medicines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,871-1,131-600.09-436.37-248.71-187.09
Depreciation & Amortization
19.0515.6610.728.218.566.23
Other Amortization
0.10.91.11.11.11.1
Loss (Gain) From Sale of Assets
0.010.030.120.050.020.12
Loss (Gain) From Sale of Investments
-17.57-27.83-44.57-22.21-3.083.01
Stock-Based Compensation
250.63118.3979.261.7731.220.72
Other Operating Activities
301.8739.59-4.320.12--
Change in Accounts Receivable
-230.72-1.253.421.260.46
Change in Accounts Payable
25.199.54-6.4732.477.292.24
Change in Unearned Revenue
----4.46-14.47-1.66
Change in Other Net Operating Assets
103.9877.296.389.23-7.147.68
Operating Cash Flow
-1,431-897.74-557.44-350.57-224.4-147.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.45-15.99-10.31-7.73-10.82-6.53
Investment in Securities
-1,322134.05-544.09-334.87-13.3-135.59
Investing Cash Flow
-1,331118.06-554.39-342.6-24.12-142.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
2,441377.09863.71392.39301.39294.6
Repurchase of Common Stock
----4.03--
Other Financing Activities
244.28244.4495.71840.830.04-0.42
Financing Cash Flow
3,172621.52959.411,229301.43294.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
409.44-158.16-152.42536.0352.924.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,441-913.73-567.74-358.3-235.22-153.71
Free Cash Flow Growth
------
Free Cash Flow Margin
-729.31%---3094.14%-664.83%-522.99%
Free Cash Flow Per Share
-7.04-4.81-3.38-3.17-2.92-2.11
Levered Free Cash Flow
-886.29-523.28-347.69-163.95-132.84-84.69
Unlevered Free Cash Flow
-835.22-508.13-347.69-163.95-132.84-84.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-114.9286.820.4136.75-13.498.72
SEC Filings: 10-K · 10-Q